Finch 1 trial of Filgotinib vs adalimulmab in MTX IR #RA pts shows FIL 200 is superior to FIL 100 or ADA 40. Drs. Fleischman/Genovese at #RWCS2020 @RWCSmtg https://t.co/rMLtnLK73B